Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2011023970) FULVIC ACID COMPOSITIONS AND THEIR USE
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2011/023970 International Application No.: PCT/GB2010/001641
Publication Date: 03.03.2011 International Filing Date: 27.08.2010
IPC:
A61K 31/352 (2006.01) ,A61P 31/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
335
having oxygen as the only ring hetero atom, e.g. fungichromin
35
having six-membered rings with one oxygen as the only ring hetero atom
352
condensed with carbocyclic rings, e.g. cannabinols, methantheline
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Applicants:
NATRACINE UK LIMITED [GB/GB]; Legh Coach House, Wilmslow Road Mottram St Andrew, Macclesfield Cheshire SK10 4QH, GB (AllExceptUS)
LEIVERS, Stephen, William [GB/GB]; GB (UsOnly)
Inventors:
LEIVERS, Stephen, William; GB
Agent:
WHITE, Nicholas John; Tangible IP Limited Bramley House 22 Otley Road Harrogate HG20DN, GB
Priority Data:
0914966.727.08.2009GB
Title (EN) FULVIC ACID COMPOSITIONS AND THEIR USE
(FR) COMPOSITIONS À BASE D'ACIDE FULVIQUE ET LEUR UTILISATION
Abstract:
(EN) Carbohydrate-derived fulvic acid (CHD-FA), a salt, ester or derivative thereof for use in the prevention, treatment or inhibition of infection by oral pathogens in a mammal, compositions, particularly compositions suitable for oral administration, comprising the same.
(FR) La présente invention concerne un acide fulvique dérivé d'hydrate de carbone, un sel, un ester ou un dérivé de celui-ci destiné à être utilisé dans la prévention, le traitement ou l'inhibition d'une infection par des agents pathogènes oraux chez un mammifère, et des compositions, notamment des compositions pharmaceutiques adaptées pour une administration orale, les comprenant.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
EP2470175US20120251467